F.inI.agingrats.Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging ratsJ Transl Med.2011103 EOF 141
According to the Wegovy SmPC, these include nausea (occurring in approximately 44% of patients in clinical trials), vomiting, diarrhoea, constipation, and abdominal discomfort
What other medications should I stop
Hwang H, Hong Y, Yoon H et al (2016) Comparison of clinical outcome between twice-weekly and thrice-weekly hemodialysis in patients with residual kidney function
A specific, transmembrane interface regulates fibroblast activation protein (FAP) homodimerization, trafficking and exopeptidase activity
Effects of metformin in heart failure: from pathophysiological rationale to clinical evidence